A comparative analysis of gene expression profiles in CML patient datasets (GSE5550 and GSE47927_GSE97562) showed that PARP1 is significantly upregulated in CML patients’ stem cells compared to healthy counterparts (Fig. 1G). The gene discussed is PARP1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.